APOA4

Apolipoprotein A-IV (also known as apoA-IV, apoAIV, or apoA4) is plasma protein that is the product of the human gene APOA4.^[5][6]

APOA4
Identifiers
Aliases	APOA4, apolipoprotein A4
External IDs	OMIM: 107690; MGI: 88051; HomoloGene: 47927; GeneCards: APOA4; OMA:APOA4 - orthologs
Gene location (Human) Chr. Chromosome 11 (human)[1] Band 11q23.3 Start 116,820,700 bp[1] End 116,823,304 bp[1]
Gene location (Mouse) Chr. Chromosome 9 (mouse)[2] Band 9 A5.2|9 25.36 cM Start 46,151,994 bp[2] End 46,154,757 bp[2]
RNA expression pattern Bgee Human Mouse (ortholog) Top expressed in jejunal mucosa mucosa of ileum duodenum right lobe of liver buccal mucosa cell vena cava internal globus pallidus pericardium Pons pylorus Top expressed in duodenum jejunum yolk sac migratory enteric neural crest cell ileum cumulus cell intestinal epithelium left lobe of liver stomach epithelium of small intestine More reference expression data BioGPS More reference expression data
Orthologs Species Human Mouse Entrez 337 11808 Ensembl ENSG00000110244 ENSMUSG00000032080 UniProt n a P06728 RefSeq (mRNA) NM_000482 NM_007468 RefSeq (protein) n/a NP_031494 Location (UCSC) Chr 11: 116.82 – 116.82 Mb Chr 9: 46.15 – 46.15 Mb PubMed search [3] [4]
Wikidata
View/Edit Human View/Edit Mouse

Gene

APOA4 resides on chromosome 11 in close linkage to APOA1 and APOC3. APOA4 contains 3 exons separated by two introns, and is polymorphic, although most of the reported sequence polymorphisms occur in exon 3. The best validated and studied non-synonymous SNPs are a glutamine → histidine substitution at codon 360 and a threonine → serine substitution at codon 347; a sequence polymorphism has also been identified in the 3'UTR of the third exon.^[7] Intra-species comparative gene sequence analysis suggests that the APOA4 gene arose from APOA1 by gene duplication approximately 270 MYA.^[8]

Function

The primary translation product of the APOA4 gene is a 396-residue preprotein, which undergoes proteolytic processing to yield apo A-IV, a 376-residue mature O-linked glycoprotein. In most mammals, including humans, apo A-IV synthesis is confined to the intestine; however in mice and rats hepatic synthesis also occurs. Apo A-IV is secreted into circulation on the surface of newly synthesized chylomicron particles. Intestinal fat absorption dramatically increases the synthesis and secretion of apo A-IV. Although its primary function in human lipid metabolism has not been established, apo A-IV has been found to:

• activate lecithin-cholesterol acyltransferase and cholesterylester transfer protein in vitro;
• play a role in the regulation of appetite and satiety in rodent models;
• display anti-oxidant and anti-atherogenic properties in vitro and in rodent models;
• modulate the efficiency of enterocyte and hepatic transcellular lipid transport in vitro.^[7]

Human apo A-IV deficiency has not been reported.

Interactions

APOA4 has been shown to interact with GPLD1.^[9]

Interactive pathway map

Click on genes, proteins and metabolites below to link to respective articles. ^{[§ 1]}

[[File:

[[

]]

[[

]]

[[

]]

[[

]]

[[

]]

[[

]]

[[

]]

[[

]]

[[

]]

[[

]]

[[

]]

[[

]]

[[

]]

[[

]]

[[

]]

[[

]]

[[

]]

[[

]]

[[

]]

[[

]]

[[

]]

[[

]]

[[

]]

[[

]]

[[

]]

[[

]]

[[

]]

[[

]]

[[

]]

[[

]]

[[

]]

[[

]]

[[

]]

[[

]]

[[

]]

[[

]]

[[

]]

[[

]]

[[

]]

[[

]]

[[

]]

[[

]]

[[

]]

[[

]]

[[

]]

[[

]]

[[

]]

[[

]]

[[

]]

[[

]]

|alt=Statin pathway edit]]

Statin pathway edit

1. The interactive pathway map can be edited at WikiPathways: "Statin_Pathway_WP430".